SCHEMBL6205925

SCHEMBL6205925

CCOC(=O)c1ccc(-c2ccccc2)c(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.60
CYP1A2 P05177 1/20 0.60
NPC1 O15118 4/20 0.51
MAPT P10636 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
POLB P06746 1/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
JMJD6 Q6NYC1 1/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
TUBB4A P04350 1/20 0.50
TUBB P07437 1/20 0.50
TUBA3C P0DPH7 1/20 0.50
TUBA1B P68363 1/20 0.50
TUBA4A P68366 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31336539 0.88 RAB9A (0.63) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL9488109 0.85 CA12 (0.66) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL3586442 0.85 RAB9A (0.53) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL29918535 0.84 MAPT (0.64) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL3910111 0.83 EGFR (0.61) RAB9AMAPTSMN1; SMN2TSHRCA12
SCHEMBL25383176 0.83 CA12 (0.55) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL28813537 0.82 RAB9A (0.51) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL28771192 0.82 RAB9A (0.51) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL28344398 0.82 RAB9A (0.53) RAB9ACYP1A2NPC1MAPTSMN1; SMN2
SCHEMBL5924878 0.82 F2RL3 (0.53) RAB9ACYP1A2NPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108884058-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2022-04-29 CN disclosed
EP-1503997-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-02-09 EP disclosed
WO-2003097617-A1 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-11-27 WO disclosed